Heat-Activated Target Therapy (Radiotherapy + Hyperthermia + Lyso-Thermosensitive Liposomal Doxorubicin) of Local-Regional Relapse in Breast Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms Euro-DIGNITY
- Sponsors Celsion Corporation
- 18 Oct 2017 Status changed from not yet recruiting to suspended.
- 30 May 2017 Planned End Date changed from 1 Nov 2019 to 1 Feb 2020.
- 30 May 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2019.